News and Events
 |
 |
 |
 |
NEWS AND EVENTS
The BioMargin project has ended on February 28th
The BioMargin project has ended on February 28th.
The consortium at the Final consortium meeting in Paris on the 20th and 21st of February
Previous event
BioMargin at the last ESOT Meeting, Barcelona 24-27 September 2017
The last ESOT meeting "Transplantation BigBang Barcelona" took place in Barcelona from the 24th to the 27th of September 2017.
BioMargin was presented in the satellite session "The coolest clinical trials in transplantation. Sponsored by EU" on Sunday 24th from 13.00 to 14.30 but also held a booth with the Cope project (financed under the same topic as BioMargin). Several of our members will also presented their results from the study.
More information here
BioMargin International Workshop and Consortium meeting BioPark Paris 2017 Feb. 21st-22nd
For information, registration now closed
Last February, BioMargin organised a public workshop on Methodological aspects of biomarker discovery and validation: BIOMARGIN as a case study
The discovery, confirmation and validation of candidate biomarkers of disease conditions, treatment efficacy or toxicity may require a number of experimental and clinical steps to achieve sufficient evidence to become transferable to the clinics, and to convince physicians to incorporate them in their practice. In this workshop, we will mostly address the methodological bottlenecks, or in contrast differentiating designs, that could be identified in different research programs on biomarkers, taking biomarkers of allograft lesions in transplantation as an example.
|
(For information) Announcement Programme Brochure |
On the 22nd of february, the 5th consortium meeting of BioMargin took place at the same venue.
4th BIOMARGIN Consortium Meeting took place in Limoges, March 15-16th
The 4th Annual Consortium meeting took place in Limoges, city of the Scientific Coordinator Pierre Marquet. All members of the consortium participated and discuss the work done in BioMargin the past year.
Stéphane Gazut presenting the last results of the CEA
3rd BIOMARGIN meeting took place in Hannover, March 30th-31st
The 3rd Annual Consortium meeting took place in Hannover. It was the opportunity to gather all members of the consortium and discuss the progress of the work plan.
The Consortium, one year later.... Dirk Valkenborg (VITO)
Biomargin has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement No 305499